Table 1 Number of subjects in study (where data are available)
SubjectsHLA-Cw*06 information: nHLA-DRB1 information: n
PsA whole cohort453465
    PsA with type I psoriasis335342
    PsA with type II psoriasis115120
Psoriasis (all type I)611NA
UIANA1621
Population controls166537
  • UIA, early undifferentiated inflammatory arthritis; PsA, psoriatic arthritis; NA, not available.

  • For three PsA cases, data were not available as to the type of psoriasis present.